ECOR logo

ELECTROCORE INC

ECORNASDAQ
πŸ† #4269 by market capEarnings Mar 18US Equity
$4.47β–Ό $0.54 (βˆ’10.78%)
Market closed Β· at close
πŸ””
Track ECOR
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 10.8%
7dβ–Ό 14.0%
14dβ–Ό 40.3%
30dβ–Ό 39.3%
ytdβ–Ό 0.8%
1yβ–Ό 6.1%
🏦Market Cap
$40M
Small Cap
πŸ“ˆRevenue Growth (YoY)
33.5%
High Growth
πŸ“ŠGross Margin
87.5%
High
πŸ’΅FCF Margin
β€”
βš–οΈP/S Ratio
1.1x
Cheap
Otter Score
β€”
Insufficient data

Trading Snapshot

Day Range
$4.06 – $4.81
52-Week Range
$4.37 – $12.70
Volume (shares)
6,187
Avg Volume (shares)
β€”
Shares Outstanding
9.0M
Next Earnings
2027-03-18

Fundamentals Snapshot

Annual Revenue
$32M
Last Q Revenue
$10M
P/E Ratio
β€”
P/S Ratio
1.1x
EPS (TTM)
$-1.66
Dividend Yield
β€”
Dilution (1yr)
+7.0%
ECOR logo

ELECTROCORE INC

ECOR
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$32Mβ–² +27.2% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
86.8%β–² +2.1% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$13Mβ–² +8.1% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$8Mβ–² +18.8% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
8.0Mβ–² +7.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$2Mβ–Ό βˆ’$2M YoY
StockOtter Β· stockotter.space

About ELECTROCORE INC

electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Insufficient data
β€”/100

Analyst Ratings

β“˜
Consensus
Buy
11 analysts
Strong Buy3
Buy7
Hold1
Sell0
Strong Sell0
Ratings as of Nov 2026

Latest News & Updates

GlobeNewsWireΒ·10d ago

Randomized Study of Non-Invasive Autonomic Neuromodulation for Long COVID Published Online in Neuromodulation

Randomized, open-label, hypothesis-generating study (541 participants enrolled; 250 met final analysis criteria) evaluated two proprietary non-invasive neuromodulation technologies, electroCore's cervical vagus nerve sti

Zacks Investment ResearchΒ·13d ago

electroCore (ECOR) Upgraded to Buy: Here's What You Should Know

electroCore (ECOR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

GlobeNewsWireΒ·17d ago

electroCore to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

ROCKAWAY, N.J., Nov. 05, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in the Canaccord Genuit

Seeking AlphaΒ·17d ago

electroCore, Inc. (ECOR) Q3 2026 Earnings Call Transcript

electroCore, Inc. (ECOR) Q3 2026 Earnings Call Transcript

Zacks Investment ResearchΒ·18d ago

electroCore, Inc. (ECOR) Reports Q3 Loss, Misses Revenue Estimates

electroCore, Inc. (ECOR) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to a loss of $0.4 per share a year ago.

MarketBeatΒ·18d ago

electroCore Q3 Earnings Call Highlights

electroCore NASDAQ: ECOR reported record third-quarter sales and a narrower loss, but revised its 2026 revenue outlook as changes to its sales organization took longer than expected to reach the full field.